|
|
Office Locations:
|
251 Post Street, Suite 412
San Francisco, CA 94108
| |
|
|
|
|
|
|
Financial Services
Information Technology
Life Sciences & Healthcare
|
|
|
|
AVP is a $1bn venture capital firm investing in seed and early stage companies through AVP Early Stage, and in growth stage companies through AVP Capital. The AXA Group is ranked the number one global insurance brand by Interbrand, and holds 91.2 billion euro in revenue and 4.7 billion euro in underlying earnings. AVP manages a $375m fund investing strategy. AVP also acts as a limited partner, investing into top-tier emerging and established early-stage and growth funds across established venture ecosystems globally. AXA also makes secondary portfolio purchases, and co-invests selectively alongside its fund managers.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
